埃维特拉韦

Name: 埃维特拉韦
Brand: 济南圣和化工有限公司

CAS 697761-98-1C23H23ClFNO5MW 447.9

济南圣和化工有限公司现供应医药中间体及原料药——埃维特拉韦（CAS 697761-98-1），分子式 C23H23ClFNO5，分子量 447.9。本页理化参数仅供参考，实际常规纯度按批次COA提供(不公开发布)，以批次 COA 及订单确认为准，支持批量采购与长期供货协议。

产品概览

CAS号	697761-98-1
分子式	C23H23ClFNO5
分子量	447.9
LogP	5.3
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	医药中间体及原料药
类别	医药中间体及原料药

应用领域

医药中间体及原料药

该产品的下游应用集中在医药中间体及原料药。不同客户工艺差异较大，我们支持按需提供样品与小批量试用。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

供应说明：埃维特拉韦常规包装为按订单/批次确认(不公开发布)，储存时应密封置于阴凉干燥处，避免与氧化剂混放。济南圣和化工有限公司支持国内物流发货，大货交期与运费以订单确认为准。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

济南圣和化工有限公司位于山东济南，主营化工原料供应，精选产品齐全，覆盖有机化学品、无机化学品、食品添加剂、医药中间体等多个大类。我们随货提供 COA 分析证书，一个工作日内回复报价，欢迎国内外采购方长期合作。

常见问题

埃维特拉韦的 CAS 号是多少？

埃维特拉韦的 CAS 号为 697761-98-1。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

埃维特拉韦有什么用途？

主要应用于医药中间体及原料药。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Elvitegravir · CAS 697761-98-1 · C23H23ClFNO5. UNII 4GDQ854U53. Solubility: <0.3 mcg/mL.

Identification

CAS Registry Number	697761-98-1
PubChem CID	5277135
Molecular formula	C23H23ClFNO5
IUPAC name	6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid
UNII (FDA)	4GDQ854U53

Computed Descriptors

Molecular Weight	447.9
XLogP3	5.3
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	7
Exact Mass	447.1248787
Monoisotopic Mass	447.1248787
Topological Polar Surface Area	87.1
Heavy Atom Count	31
Formal Charge	0

Physical & Chemical Properties

Solubility	<0.3 mcg/mL

Regulatory Status

GHS notification summary	33.3% (1 / 3)

GHS Hazard Classification

GHS notification summary	33.3% (1 / 3)
Reported hazard statements	H400 (33.3%), H410 (33.3%), H411 (33.3%), H412 (33.3%)

This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.

H400 (33.3%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

Documented Uses

Elvitegravir in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) is indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.
Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antiviral Agents; Anti-HIV Agents; Anti-Retroviral Agents; HIV Integrase Inhibitors
Avoid St. John's Wort. This herb induces the CYP3A metabolism of elvitegravir. Therefore, it may reduce the serum concentration of elvitegravir and its effectiveness.
Take separate from antacids. Take at least 2 hours before or after antacids.
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
Compounds which inhibit or antagonize biosynthesis or actions of integrase.

Synonyms

Elvitegravir; 697761-98-1; GS-9137; JTK-303; Vitekta; GS 9137; JTK 303; elvitegravirum; JTK303; CHEBI:72289; GS9137; 4GDQ854U53; DTXSID101021650; VITEKTA COMPONENT ELVITEGRAVIR; STRIBILD COMPONENT ELVITEGRAVIR; RefChem:58903

Frequently Asked Questions

What are the CAS number and molecular formula of Elvitegravir?

CAS 697761-98-1; molecular formula C23H23ClFNO5; molecular weight — g/mol.

What other names is Elvitegravir known by?

Elvitegravir, 697761-98-1, GS-9137, JTK-303, Vitekta, GS 9137.

Is Elvitegravir classified as hazardous?

33.3% of GHS notifications report no hazard classification (1 of 3).

What are the key physical properties of Elvitegravir?

Solubility: <0.3 mcg/mL.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.